Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 223,680,784 papers from all fields of science
Search
Sign In
Create Free Account
ovarian serous tumor
Known as:
Serous Neoplasm of Ovary
, Serous Tumor of the Ovary
, serous ovarian tumor
Expand
A benign, borderline, or malignant epithelial tumor of the ovary characterized by the presence of neoplastic epithelial cells that, in well…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
7 relations
Epithelial Cells
Epithelium
Female Reproductive System
Neoplastic Cell
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
miRNA‐301b‐3p accelerates migration and invasion of high‐grade ovarian serous tumor via targeting CPEB3/EGFR axis
Fengying Liu
,
Guilian Zhang
,
Shi-Ming Lv
,
Xin Wen
,
Peishu Liu
Journal of Cellular Biochemistry
2019
Corpus ID: 73505390
High‐grade ovarian serous carcinoma (HGS‐OvCa), a type of ovarian cancer with poor prognosis due to distant metastasis, is…
Expand
Highly Cited
2001
Highly Cited
2001
Expression of cell cycle regulators p57(KIP2), cyclin D1, and cyclin E in epithelial ovarian tumors and survival.
Elizabeth Rosenberg
,
Rita I. Demopoulos
,
+4 authors
Elizabeth W. Newcomb
Human Pathology
2001
Corpus ID: 24963509
The search for new prognostic indicators is especially important in the diagnosis and treatment of ovarian cancer because…
Expand
1999
1999
In serous ovarian neoplasms the frequency of Ki-ras mutations correlates with their malignant potential
Christian J. Haas
,
J. Diebold
,
A. Hirschmann
,
H. Rohrbach
,
U. Löhrs
Virchows Archiv
1999
Corpus ID: 361459
Ki-ras mutations by denaturing gradient gel electrophoresis (DGGE) and direct sequencing after microdissection. Point mutations…
Expand
1996
1996
Increased serum 72 KDa metalloproteinase in serous ovarian tumors: comparison with CA 125.
G. Garzetti
,
A. Ciavattini
,
G. Lucarini
,
G. Goteri
,
C. Romanini
,
G. Biagini
Anticancer Research
1996
Corpus ID: 45579904
72 KDa metalloproteinase (MMP-2) is an enzyme present in neoplastic cells and also in normal fibroblasts. It specifically cleaves…
Expand
1993
1993
DNA flow cytometric analysis of serous ovarian tumors of low malignant potential
J. Seidman
,
H. Norris
,
J. L. Griffin
,
C. Hitchcock
Cancer
1993
Corpus ID: 20127730
Background. Ovarian serous tumors of low malignant potential (STLMP) occasionally progress; a small percentage of patients die of…
Expand
Review
1990
Review
1990
Serous ovarian tumors of low malignant potential with peritoneal implants
D. Gershenson
,
Elvio G. Silva
Cancer
1990
Corpus ID: 23606330
Between 1956 and 1985, 82 patients with metastatic low‐grade serous ovarian carcinoma, subsequently reclassified by pathologic…
Expand
Review
1986
Review
1986
Invasive and noninvasive implants in ovarian serous tumors of low malignant potential
H. Michael
,
L. Roth
Cancer
1986
Corpus ID: 2415067
Ovarian serous tumors of low malignant potential (“borderline” serous tumors) are classified according to the histologic features…
Expand
Highly Cited
1984
Highly Cited
1984
Prognostic significance of nuclear DNA content in serous ovarian tumors.
K. Erhardt
,
G. Auer
,
+5 authors
A. Zetterberg
Cancer Research
1984
Corpus ID: 42041391
Specimens from 73 serous ovarian cancers were examined with respect to DNA content of the tumor cells. The prognostic value of…
Expand
1984
1984
Amylase from human serous ovarian tumors: purification and characterization.
J. Zakowski
,
M. Gregory
,
D. Bruns
Clinical Chemistry
1984
Corpus ID: 9920368
Human serous-type ovarian tumors contain an acidic isoenzyme of amylase. Previous attempts at purification of tumor amylases have…
Expand
Review
1965
Review
1965
Papillary ovarian tumors
J. J. Malloy
,
M. Dockerty
,
J. S. Welch
,
A. Hunt
1965
Corpus ID: 58438332
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE